New Delhi: Eminent scientist and member of NITI Aayog VK Saraswat said on Tuesday that there is no point in arguing about allopathy and Ayurveda. He said that these two are different and useful medical methods. He stressed the need for more research to make Ayurveda more acceptable among the masses.
Saraswat, who was associated with the development of the drug prepared for the treatment of Kovid by the Defense Research and Development Organization (DRDO), made it clear that DRDO’s medicine has nothing to do with Patanjali. He said this amid reports that the medicine is related to the research of Patanjali Ayurved.
The NITI Aayog member has said the above things amidst the objection raised on the statement of Yoga Guru Ramdev of Indian Medical Association (IMA) on Allopathy and Ayurveda. Ramdev had questioned the effectiveness of allopathy in the treatment of Kovid infection, which the IMA strongly opposed. Ramdev is associated with the operation of Patanjali Ayurveda.
Saraswat said that India has had traditional medical systems for thousands of years and Ayurvedic medicines have been known to improve the immunity of people.
“I think Ayurveda and Allopathy are two streams of medicine and go hand in hand… One has a special role while the other has a different role,” he said.
In the midst of the ongoing controversy in some sections over allopathy and Ayurveda, Saraswat said, “There is really no point in arguing. Both methods are useful.
He said, “My opinion is that the Ayurvedic system of medicine should do more and more research to understand the scientific methods for greater acceptance in the society, which has been done in allopathy.”
It is noteworthy that last month, Union Health Minister Harsh Vardhan termed Ramdev’s statement regarding allopathic medicines as “very unfortunate” and asked him to withdraw the statement. Harsh Vardhan said that this statement will hurt the honor of the Corona warriors and weaken the morale of the health workers. After this Ramdev withdrew his statement.
When asked whether the covid drug 2-DG developed by DRDO is related to Patanjali Ayurved, Saraswat said, “Absolutely not”.
“It has nothing to do with (2-DG) Patanjali. Patanjali doesn’t know anything about it. This is not their job.” Former DRDO chief Saraswat said that he was the scientific advisor when this drug was developed.
He elaborated, “When the drug was developed, it was originally intended to help treat patients suffering from radiation-induced cancer… We do radiation therapy to treat that cancer. ”
According to the member of NITI Aayog, during the radiation process not only cancer cells die but healthy cells also die. This causes great harm to the human body.
He said, “You know cancer cells want energy all the time. That’s why they take energy from our body. Our body gives them energy in the form of glucose. We started injecting instead of taking ‘sugar’ from the body. This drug is like glucose but in reality it is not glucose, there is no energy in it.
He said that once they are weakened, low doses of radiation can be given to kill the cancer cells and will not be harmful to the healthy cells.
DRDO’s 2-DG drug has been approved by the Drug Controller General (DGCI) for emergency use as adjunctive therapy in corona virus patients with moderate to severe symptoms.